[Two cases of recurrent oral cancer responding to radiochemotherapy with selective intra-arterial infusion of nedaplatin].
Yoshio Yamashita(Saga University), Masaaki Goto(SHOWA Medical University), Y Kuroda, Tatsuya Yamamoto(Kansai University of Welfare Sciences)
PubMed
April 1, 2009
Cited by 0
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor
|Journal of Biological Chemistry|1998|203